ImmuCell (ICCC) Metrics: History & Chart

ImmuCell Corporation(ICCC)

Biotechnology · Portland, ME

$9.97+0.22 (+2.26%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About ImmuCell Corporation

ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.

Portland, ME

73 employees

immucell.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: F. Olivier Te Boekhorst

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-1.32%
30D Total Return	-1.52%
YTD Total Return	+58.54%
1Y Total Return	+54.52%
3Y Total Return	+86.07%
5Y Total Return	+3.29%
10Y Total Return	+27.51%
15Y Total Return	+65.85%
20Y Total Return	+102.47%

2026	+58.54%
2025	+19.42%
2024	+1.18%
2023	-16.56%
2022	-23.75%
2021	+34.46%
2020

CAGR TTM	+54.20%
CAGR 3Y	+22.99%
CAGR 5Y	+0.65%
CAGR 10Y	+2.46%
CAGR 15Y	+3.43%
CAGR 20Y	+3.59%

PE Ratio	115.25
PE Ratio Avg TTM	25.97
PE Ratio Avg 3Y	27.51
Current VS TTM Avg	+343.79%
Current VS 3Y Avg	+318.93%
Current VS 5Y Avg	+36.39%

All Metrics

ICCC Valuation Metrics

ICCC Stock Price Metrics

ICCC Dividend Metrics

ICCC Growth Rate Metrics

ICCC Discounted Cash Flow Metrics

ICCC Returns By Period

ICCC Yearly Returns

ICCC Average Annual Returns By Period (CAGR)

ICCC Revenue Metrics

ICCC PE Ratio Metrics

ICCC PS Ratio Metrics

ICCC PB Ratio Metrics

ICCC Price to Free Cash Flow Ratio Metrics

ICCC Debt to Equity Ratio Metrics

ICCC PEG Ratio Metrics

ICCC FCF Yield

ICCC Earnings Yield

ICCC EBITDA Yield

ICCC OCF Yield

ICCC EV/EBIT Ratio Metrics

ICCC EV/EBITDA Ratio Metrics

ICCC EV/Assets Ratio Metrics

ICCC EV/Sales Ratio Metrics

ICCC Current Ratio Metrics

ICCC Quick Ratio Metrics

ICCC ROIC Metrics

ICCC Return on Assets Metrics

ICCC Return on Equity Metrics

ICCC Net Profit Margin Metrics

ICCC Gross Profit Margin Metrics

ICCC Tax Rate Metrics

PS Ratio	2.92
PS Ratio Avg TTM	2.48
PS Ratio Avg 3Y	2.09
Current VS TTM Avg	+17.55%
Current VS 3Y Avg	+39.58%
Current VS 5Y Avg	+18.78%

PB Ratio	2.86
PB Ratio Avg TTM	2.44
PB Ratio Avg 3Y	1.64
Current VS TTM Avg	+17.17%
Current VS 3Y Avg	+74.03%
Current VS 5Y Avg	+67.21%

PFCF Ratio	21.26
PFCF Ratio Avg TTM	49.21
PFCF Ratio Avg 3Y	51.81
Current VS TTM Avg	-56.80%
Current VS 3Y Avg	-58.96%
Current VS 5Y Avg	-58.96%

Debt/Equity Ratio	0.40
Debt/Equity Ratio Avg TTM	0.45
Debt/Equity Ratio Avg 3Y	0.55
Current VS TTM Avg	-12.11%
Current VS 3Y Avg	-27.42%
Current VS 5Y Avg	-17.20%

PEG Ratio	1.56
PEG Ratio Avg TTM	2.81
PEG Ratio Avg 3Y	2.81
Current VS TTM Avg	-44.54%
Current VS 3Y Avg	-44.54%
Current VS 5Y Avg	-15.14%

FCF Yield	4.70%
FCF Yield Avg TTM	2.62%
FCF Yield Avg 3Y	2.45%
Current VS TTM Avg	+79.36%
Current VS 3Y Avg	+91.81%
Current VS 5Y Avg	+91.81%

Earnings Yield	0.87%
Earnings Yield Avg TTM	3.26%
Earnings Yield Avg 3Y	3.77%
Current VS TTM Avg	-73.31%
Current VS 3Y Avg	-76.90%
Current VS 5Y Avg	-52.57%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	24.10
Ev/Ebit Ratio Avg TTM	34.08
Ev/Ebit Ratio Avg 3Y	34.41
Current VS TTM Avg	-29.28%
Current VS 3Y Avg	-29.97%
Current VS 5Y Avg	-36.70%

Ev/Ebitda Ratio	14.91
Ev/Ebitda Ratio Avg TTM	15.77
Ev/Ebitda Ratio Avg 3Y	17.75
Current VS TTM Avg	-5.47%
Current VS 3Y Avg	-16.00%
Current VS 5Y Avg	-36.70%

Ev/Assets Ratio	2.00
Ev/Assets Ratio Avg TTM	1.77
Ev/Assets Ratio Avg 3Y	1.29
Current VS TTM Avg	+12.99%
Current VS 3Y Avg	+55.15%
Current VS 5Y Avg	+53.90%

Ev/Sales Ratio	3.04
Ev/Sales Ratio Avg TTM	2.76
Ev/Sales Ratio Avg 3Y	2.60
Current VS TTM Avg	+10.33%
Current VS 3Y Avg	+16.84%
Current VS 5Y Avg	+6.20%

Current Ratio	4.75
Current Ratio Avg TTM	4.38
Current Ratio Avg 3Y	3.58
Current VS TTM Avg	+8.53%
Current VS 3Y Avg	+32.72%
Current VS 5Y Avg	+3.39%

Quick Ratio	2.71
Quick Ratio Avg TTM	2.20
Quick Ratio Avg 3Y	1.64
Current VS TTM Avg	+23.16%
Current VS 3Y Avg	+65.40%
Current VS 5Y Avg	-3.25%

ROIC	8.16%
ROIC Avg 3Y	(3.62%)
ROIC Avg 5Y	(3.11%)
Current VS 3Y Avg	+325.73%
Current VS 5Y Avg	+362.05%
Current VS 10Y Avg	+598.32%

ROA	1.69%
ROA Avg TTM	0.48%
ROA Avg 3Y	(0.57%)
Current VS TTM Avg	+251.17%
Current VS 3Y Avg	+397.54%
Current VS 5Y Avg	+303.41%

ROE	2.51%
ROE Avg TTM	2.10%
ROE Avg 3Y	(8.89%)
Current VS TTM Avg	+19.64%
Current VS 3Y Avg	+128.24%
Current VS 5Y Avg	+136.68%

Net Profit Margin	2.57%
Net Profit Margin Avg TTM	2.43%
Net Profit Margin Avg 3Y	(6.75%)
Current VS TTM Avg	+5.63%
Current VS 3Y Avg	+138.05%
Current VS 5Y Avg	+135.22%

Gross Profit Margin	40.32%
Gross Pft Margin Avg TTM	40.74%
Gross Pft Margin Avg 3Y	33.84%
Current VS TTM Avg	-1.02%
Current VS 3Y Avg	+19.14%
Current VS 5Y Avg	+10.94%

Tax Rate	2.44%
Tax Rate Avg 3Y	0.95%
Tax Rate Avg 5Y	1.29%
Current VS 3Y Avg	+157.04%
Current VS 5Y Avg	+89.10%
Current VS 10Y Avg	+37.29%